Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medpace Holdings, Inc. Director's Dealing 2019

Sep 17, 2019

30442_dirs_2019-09-17_b01b3766-95e2-4e6a-9028-616718ab27f5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medpace Holdings, Inc. (MEDP)
CIK: 0001668397
Period of Report: 2019-09-13

Reporting Person: Medpace Investors, LLC (10% Owner)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-09-13 Employee Stock Option (Right to Buy) $14.41 P 117132 Acquired 2021-06-10 Common Stock (117132) Direct
2019-09-13 Employee Stock Option (Right to Buy) $14.41 P 17035 Acquired 2021-07-07 Common Stock (17035) Direct
2019-09-13 Employee Stock Option (Right to Buy) $16.20 P 73265 Acquired 2022-03-31 Common Stock (73265) Direct
2019-09-13 Employee Stock Option (Right to Buy) $16.88 P 10887 Acquired 2022-07-31 Common Stock (10887) Direct
2019-09-13 Employee Stock Option (Right to Buy) $18.23 P 11112 Acquired 2023-03-31 Common Stock (11112) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 7751125 Direct

Footnotes

F1: Stock options were purchased pursuant to the Tender Offer Statement on Schedule TO (the "Offer") filed with the Securities and Exchange Commission on August 5, 2019 (together with any subsequent amendments or supplements thereto). Pursuant to the Offer, MPI purchased 229,431 vested stock options from Eligible Holders (as defined in the Offer) upon the terms and conditions set forth in the Offer. The Offer expired at 11:59 p.m., Eastern Time, on September 13, 2019.

F2: The stock options subject to this purchase are fully vested and exercisable.